Talaris Therapeutics, Inc. has been dropped from NASDAQ Biotechnology Index.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
15.78 USD | +1.58% | -0.34% | -39.74% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-39.74% | 398M | |
+10.44% | 106B | |
+0.82% | 104B | |
+6.72% | 23.25B | |
-13.89% | 22.5B | |
-6.64% | 18.7B | |
-37.26% | 17.95B | |
-10.98% | 16.99B | |
+8.67% | 14.26B | |
+41.08% | 12.76B |
- Stock Market
- Equities
- TRML Stock
- News Tourmaline Bio, Inc.
- Talaris Therapeutics, Inc.(NasdaqGM: TALS) dropped from NASDAQ Biotechnology Index